acoramidis hydrochloride

acoramidis hydrochloride (ATTRUBY) is an FDA-listed pharmaceutical active ingredient. Associated with BridgeBio Oncology Therapeutics. Route of administration: oral. Current US regulatory status: approved.

ATTRUBY is a marketed brand name for acoramidis hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

acoramidis hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.